are not observed until postnatal stages after completion of embryogenesis. These findings are unexpected given the large-scale cell migration and morphogenetic events that occur during mouse embryogenesis (16). The MMP14/MT1-MMP knockout mice have the strongest post-embryonic phenotypes (14,15) and this membrane-tethered MMP is a key activator of the proMMP2 zymogen (17). It is therefore notable that mice deficient for both MMP14 and MMP2 show a stronger phenotype than either single mutant, dying shortly after birth with a variety of defects (18). At minimum, the mouse MMP knockout data indicate that specific MMPs are not essential regulators of embryonic development. Is this a simple matter of redundancy between MMP family members or are the MMP knockout phenotypes extremely subtle or both?
ABSTRACT
Matrix metalloproteinases (MMPs), adamalysins, astacins, and serralysins are members of the metzincin superfamily of proteases. MMPs constitute a large protein family of both secreted and membranetethered enzymes that are synthesized as zymogens (proMMP) and activated by a cysteine-switch mechanism. First described over 50 years ago by Gross and Lapiere as a collagenolytic activity in amphibian tissues, the human MMP family now encompasses 23 different genes whose encoded proteins are capable of cleaving a variety of extracellular matrix protein substrates. Since their expression is upregulated in many cancer cell types, MMPs have received much attention particularly in the areas of tumor progression and metastasis. However, in terms of normal developmental processes, much less is known regarding MMP function and substrate identity. Data from knockout mouse studies support the notion that MMPs are not essential regulators of embryonic development, suggesting redundancy between MMPs or the presence of subtle phenotypes. However, studies on MMP function in other model systems indicate a larger role for MMP-dependent proteolysis during embryonic processes. Here, we review the current knowledge of MMPs from diverse model systems ranging from flowering plants and invertebrates to non-mammalian vertebrates.
INTRODUCTION
First described in amphibian tissues (1), matrix metalloproteinases (MMPs) are proteolytic enzymes and members of the metzincin superfamily of zinc-dependent endopeptidases (2). MMPs are capable of cleaving extracellular matrix (ECM) and non-ECM proteins including adhesion molecules, ligands, and receptors. The human genome contains 23 MMP genes and 4 genes encoding tissue inhibitors of metalloproteinases (TIMPs). Most human MMP proteins have a similar domain organization that includes a signal peptide, propeptide domain, catalytic domain, hinge region, and a hemopexin domain. While many MMPs are secreted as inactive zymogens requiring proprotein convertase activity to remove the N-terminal propeptide domain for activation (3), six MMPs are membrane-tethered and are activated in the trans-Golgi network by convertases (4) or by alternative mechanisms such as auto-proteolysis (5). These so-called MT-MMPs possess either a glycosylphosphatidylinositol (GPI) anchor or a type I transmembrane domain with a short cytoplasmic tail and are regulated by vesicular trafficking pathways (6).
It has long-been recognized that MMP-mediated collagenolytic activity correlates with tumor histology/ grade (7) (reviewed in (8)). Thus, the general consensus is that increased MMP-dependent ECM degradation promotes tumor progression and metastasis. This thinking has prompted much interest in the field of MMP research. Knockout mice for several different MMPs have been created and while some show no developmental defects (9-13), some exhibit severe skeletal and connective tissue abnormalities (14, 15) . In cases where MMP loss-of-function phenotypes are apparent, these
HYDRA
Hydra is a member of the phylum Cnidaria and thus arose early during metazoan evolution, before the separation of protostome and deuterostome branches. Due to the ability to regenerate their entire body, hydra is a popular model organism for studying the cellular basis of tissue remodeling (see (25,26) for reviews). Notably, a hydra matrix metalloproteinase (HMMP) and its associated ECM degradation were shown to be required for regeneration of both the head and foot process (27, 28) . Analysis of the HMMP protein sequence (484 amino acids) identified several features in common with vertebrate MMPs including a signal peptide, propeptide domain, catalytic domain, hinge region, and a C-terminal hemopexin domain (27). It lacks both a transmembrane domain and GPI anchor site and is thus likely to be a secreted protein. Compared to both secreted and membrane-tethered human MMPs, HMMP has an overall amino acid sequence identity of 31-35% and as high as 47% when only the catalytic domains are compared. While both the cysteine-switch and Zn 2+ -binding regions are highly conserved between HMMP and vertebrate MMPs, HMMP has unique properties such as the lack of key cysteine residues in the hemopexin domain (27). While HMMP is able to cleave a variety of hydra ECM substrates (laminin and collagen I), it is unable to degrade certain human ECM proteins including laminin, fibronectin, and both types I-and IV-collagen (27). The inability of hydra MMPs to cleave human ECM substrates might be due to differences in hemopexin domain structure that could prevent hydra MMPs from physically interacting with human ECM proteins. HMMP enzymatic activity is inhibited by the synthetic MMP inhibitors GM6001 (galardin/ilomastat) and Matlistatin and by recombinant TIMP1 (27).
The hydra body plan is organized as an epithelial bilayer consisting of ectoderm and endoderm with a layer of ECM in between. Experiments utilizing whole-mount in situ hybridization have shown that HMMP mRNA is expressed within the endoderm of the adult polyp along the entire body length (27). However, HMMP is enriched in both the tentacles and the foot process just above the cells of the basal disc (27). It is notable that this mRNA expression pattern mirrors that of the HMMP cleavage substrate laminin b1. In terms of HMMP function, longterm exposure of adult hydra polyps to GM6001 caused the reversible de-differentiation of epithelial basal disc cells or alternatively the inhibition of transdifferentiation of body column cells to basal disc cells (27) . Therefore, HMMP functions to regulate cell differentiation likely through effects on ECM cleavage and remodeling. In terms of foot process tissue regeneration, the expression of HMMP mRNA is strongly upregulated at sites of amputation and to continue for at least 48 hours during foot regeneration (27). During head regeneration, both HMMP and genes encoding the ECM proteins laminin b1 and collagen I are upregulated three hours after decapitation with increases in protein levels being observed several hours later (28). Typical of other metazoans, hydra ECM consists of basement membrane and fibrillar interstitial ECM (29) and both are lost and then reformed during tissue regeneration following amputation. Notably, the biogenesis of ECM during tissue regeneration is associated with the expression of HMMP suggesting a regulatory role for proteolysis during cell-ECM interactions underlying ECM assembly and cell differentiation (28).
AMPHIOXUS
The first reported cloning of an MMP family member in amphioxus occurred in 2012 (30). This gene was named BbMMPL2 and encodes a 494 amino acid protein with a predicted mass of 54.7. kDa. This MMP contains a propeptide domain, catalytic domain, hinge region, and C-terminal hemopexin domain. Sequence analysis indicated that amphioxus BbMMPL2 has an overall identity of 33-36% with human MMPs (higher identity in the catalytic domain) (30). BbMMPL2 contains the highly conserved serine at position 214 indicative of vertebrate MMP family members. In terms of proteolysis, recombinant active BbMMPL2 was shown to cleave gelatin, type IV collagen, fibronectin, and laminin, an enzymatic activity that was inhibited by EGTA, GM6001, and human TIMP1/TIMP2 (30). While BbMMPL2 mRNA is expressed in various adult organs including hepatic diverticulum, gut, ovary, and testes, expression in the developing embryo remains to be determined (30).
SEA URCHIN
In contrast to the organisms discussed thus far, the sea urchin (Strongylocentrotus purpuratus) genome contains at least 26 potential MMP genes (Sp-MMP) and 10 TIMP genes (31,32). Interestingly, there are at least nine membrane-tethered MMPs in the sea urchin genome (Sp-MT-MMP). Because most sea urchin MMP genes are the result of duplications of ancestral genes, it is not possible to determine orthologous relationships between sea urchin and vertebrate MMPs. Several sea urchin MMP proteins possess the typical architecture found in vertebrate MMPs such as catalytic and hemopexin domains, while several have unique structures (31). Utilizing a whole-genome tiling array approach, it was found that 19/26 sea urchin MMP genes and 9/10 TIMP genes are transcribed during embryogenesis (blastula and gastrula stages) (33). These data suggest that sea urchin MMPs might regulate specific morphogenetic processes associated with early development. Indeed, it is well recognized that a collagen-containing ECM is required for sea urchin gastrulation (34). Further work is needed to determine whether sea urchin ECM proteins are actual proteolytic substrates for MMP family members. One study on adult sea urchins from the order Camarodonta (Paracentrotus lividus) provided evidence that MMP activity might regulate the tensile strength of specific ligaments (35) .
WORM
The genome of the nematode Caenorhabditis elegans contains at least 6 genes encoding potential MMPs (named zinc metalloproteinase; ZMP-1 through ZMP-6) (36, 37) . With some variation, worm MMP proteins have typical vertebrate MMP domains including a signal peptide, hinge region, catalytic domain, and hemopexin domain (36) . ZMP-5 does not contain an inhibitory cysteine-switch sequence and ZMP-1 has a predicted GPI membrane anchor. Amino acid identity between ZMP-2 and ZMP-3 and human MMP1 is 34% and 45%, respectively (38) . ZMP-3 demonstrated proteolytic activity towards gelatin but not type I collagen or carboxymethylated transferrin (38) . Using a fluorescence-quenching substrate, it was shown that the enzymatic activities of both ZMP-2 and ZMP-3 are inhibited by recombinant human TIMP1 and TIMP2 and by synthetic chemical MMP inhibitors (BB94/ batimatstat and CT543) (38) . Functional studies utilizing RNAi to knockdown zmp-2 expression demonstrated a requirement for ZMP-2 during development from larval to adult stages (36) . In addition, the molting process was retarded in zmp-2 knockdown animals suggesting a potential role for this protease in the process of ecdysis.
One of the most studied C. elegans MMPs is ZMP-1 and its role during the process of anchor cell (a specialized uterine cell) invasion of the basement membrane (reviewed in (39) ). The larval basement membrane is similar to that from vertebrates containing the ECM proteins laminin, type IV collagen, perlecan, and nidogen (40). During the 90-minute transmigration process, an anchor cell first develops an invasive front that interfaces with the basement membrane followed by the formation of protrusions that will breach the basement membrane. Loss of function mutations in the transcription factor fos-1a produce anchor cells that can form polarized protrusions and target them to the basement membrane but that are unable to breach this ECM barrier (37) . Although zmp-1 is a transcriptional target of FOS-1a, null mutations in zmp-1 only mildly affect anchor cell invasion indicating that this MMP functions redundantly with other proteases (37) . Such a redundant and/or subtle role for ZMP-1 during anchor cell invasion suggests that the process of breaching the basement membrane is complex and involves more than proteolytic degradation of ECM proteins. Indeed, elegant work by Ihara et al. demonstrated that at later stages of uterine/vulval development, large ECM gaps form through a process of basement membrane sliding and targeted cellular adhesion (41).
FLY
Since the identification of two fruit fly MMPs over a decade ago, Drosophila melanogaster has continued to be an informative model for the study of MMP function (reviewed in (42)). The fly Mmp genes were originally named Dm1-MMP and Dm2-MMP (43, 44) and are now more commonly referred to as Mmp1 and Mmp2 to better align with human MMP nomenclature. However, fly Mmp1 and Mmp2 are not orthologous to human MMP1 and MMP2 (45) . Fly Mmp1 encodes a secreted protein while the Mmp2 protein contains a GPI anchor site and localizes to cell membranes (43, 45) . Each of these MMPs contains typical domains found in vertebrate proteins including a signal peptide, propeptide domain, catalytic domain, hinge region, and hemopexin domain (43, 44) . Both exhibit proteolytic activity towards peptide substrates and Mmp1 was additionally shown to cleave fibronectin and type IV collagen. The D. melanogaster genome encodes just one TIMP (called Timp) and it is most similar to human TIMP3 (46) . Notably, Timp can inhibit both Mmp1 and Mmp2 in addition to several human MMPs; Mmp1 is also inhibited by human TIMPs (45, 46) . These data once again confirm the conservation between invertebrate and vertebrate MMPs.
Analyses of Mmp1 gene expression by northern blot first identified transcripts at late stages of embryogenesis (15 hours of development), after gastrulation (45) . By contrast, Mmp2 was detected between 8-12 hours (45) . Each MMP is expressed in diverse embryonic and larval tissues including the site of dorsal closure, mesoderm, ectoderm, the developing gut, and cells of both the central and peripheral nervous systems (45) . Despite expression in embryonic tissues, Mmp1Mmp2 double mutant animals complete embryogenesis and hatch (45) . While these data indicate that fly metalloproteinases are not essential for embryogenesis, they do not show whether Mmp1 or Mmp2 play subtle roles in specific cellular processes underlying embryonic development. At post-embryonic stages, Mmp1 and Mmp2 are required for tissue remodeling related to tracheal growth, metamorphosis, and wound healing (45, 47, 48) . Fly tumor cells also utilize Mmp1 activity to metastasize to the ovary (49) . Taking advantage of the genetic tools of the fly system, a structure-function study was performed to interrogate the role of the Mmp1 catalytic and hemopexin domains (47) . Interestingly, while the catalytic domain is required for all Mmp1-dependent functions, the hemopexin domain is not required for tracheal tissue remodeling (47) . The hemopexin domain however, is required for tissue invasion during metamorphosis. These findings underscore the specificity of interactions between Mmp1 and different substrates and implicate non-hemopexin domains in substrate recognition events required for certain developmental processes.
FROG
There have been 26 MMPs identified in Xenopus laevis (50) . Twenty of these have vertebrate homologs and fifteen have human identified homologs. The other six MMPs represent MMPs that are novel to X. laevis. Since X. laevis has a pseudotetraploid genome several MMPs have duplicate copies including XMMP1, XMMP7, XMMP13, XMMP14, XMMP24, and XMMP28. Of the six novel MMPs, XMMP-N1 and XMMP-N3 are found in both X. laevis and X. tropicalis. The other four novel MMPs are found only in X. tropicalis. Based on the similarities of these novel MMPs to other known MMPs, these MMPs probably arose by gene duplication (50) . The X. laevis genome also encodes at least two TIMP homologs (TIMP2 and TIMP3) (51) .
During development macrophages must migrate from the blood islands, where they form, throughout the body. Three MMPs have been shown to play a role in this migration: XMMP7, XMMP9 and XMMP18. XMMP7 lacks a hemopexin domain and has a variety of ECM substrates (50) . XMMP9 is a gelatinase. XMMP18 is known to cleave gelatin and collagen (52) . Early in embryogenesis XMMP7 is expressed in the area where the blood islands eventually form. As development progresses it begins to be expressed throughout the embryo between the epidermis and mesoderm in a spotted pattern indicating its localization within single cells (53). Supporting this notion, XMMP7 colocalizes with the macrophage marker POX2 (52) . Both XMMP9 and XMMP18 have similar expression patterns to XMMP7 (52) and appear to be expressed specifically and exclusively within macrophages during development. © 1996-2015 Through loss of function and rescue experiments it was shown that XMMP7, XMMP9 and XMMP18 are each individually necessary for macrophage migration. Loss of function of any one of these MMPs inhibits macrophage migration and there are several possible mechanisms whereby these MMPs function (52, 53) . XMMP7 cleaves and activates XMMP9 and potentially XMMP18 (52). β4-integrin and syndecan-1 are present in the area of the migrating macrophages and these are known substrates of XMMP7. It is therefore possible that these proteins play a role in the migration process through interactions with XMMP7 (53). Another possible mechanism is through the MMP-dependent cleavage of chemokines. Chemokines may be an unidentified substrate of either XMMP7, XMMP9 or XMMP18 (52) . Current data indicate that these three MMPs promote macrophage migration by cleavage of ECM, activation of chemokines, or a combination of both.
XMMP14 is a membrane bound MMP that cleaves many ECM substrates including fibronectin, laminin and collagen (50) . It begins to be expressed at gastrulation and continues through hatching. Its expression is contained in the hindbrain at rhombomeres three and five and in migrating neural crest cells (53). XMMP2, a gelatinase, is also expressed in migrating neural crest cells starting at tailbud stage. In later stages of embryogenesis, XMMP14 and XMMP2 are co-expressed (54) and XMMP14 has been shown to activate XMMP2 (53). Their co-expression in neural crest indicates an important role during the migration of these cells but the exact mechanism is unknown (54).
There remain several frog MMPs whose expression patterns have been characterized yet their biological function remains unknown. XMMP28 is expressed at low levels within the fertilized egg (55). Its expression increases starting during mid-neurulation where it is localized in the developing neural tissue. Later in development it colocalizes with the axon marker acetylated-tubulin. It continues to be expressed throughout development in the peripheral and central nervous systems. Due to the expression of XMMP28 later in neurulation, it is predicted that XMMP28 is involved in the maturation but not migration of the neurons (55).
XMMP16/MT3-MMP is a membrane-tethered MMP that also has a soluble form produced by the cleavage of its extracellular domain (56). Its mRNA begins to be expressed during the tailbud stage in the anterior neural tissue. Through the use of mRNA injection experiments it was shown that the membrane bound and the soluble forms have different roles during development. Those embryos injected with mRNA encoding the soluble form of XMMP16 showed neural tube closure defects and defects in the somites. Injection of the soluble form also showed an increase in gelatinase activity. This could be through the activation of the gelatinase XMMP2 because XMMP16 can activate XMMP2. The defects and increased gelatinase activity were not present in embryos injected with full length XMMP16 mRNA. Although the exact mechanism and role of XMMP16 in development is still unknown, these data indicate that the membrane bound and soluble forms have distinct roles (56). XMMP15, another membrane-tethered MMP, is expressed during all stages of embryogenesis (53). Early in development it is expressed throughout the ectoderm while at later stages XMMP15 localizes to the ventral ectoderm (53) suggesting a possible function in the epidermis.
XMMP11 is classified as a stromelysin (57). XMMP11 mRNA is expressed in the branchial arches and the dorsal endoderm in the tailbud stage embryo. XMMP11 overexpression causes death during late embryogenesis (57). XMMP24 is a transmembrane MMP that has been shown to cleave fibronectin and proteoglycans (57). Overexpression of XMMP24 also caused late stage lethality and showed a dose dependent effect on the length of the body axis. Notably, XMMP11 was shown to cleave the non-integrin laminin receptor during intestinal remodeling events associated with metamorphosis (58,59).
ZEBRAFISH
Compared with humans, the zebrafish genome has a similar number of mmp and timp genes (~27 MMPs and ~6 TIMPs), yet the complexity of zebrafish MMP and TIMP family members is lower. For a detailed sequence and phylogenetic analysis of zebrafish MMPs and TIMPs, see (60). While zebrafish appear to lack orthologs of human MMP1, 3, 8, 10, 12, 26, 27 , and TIMP1 (60), the zebrafish genome contains homologous genes for each of the six human membrane-tethered MMPs including additional isoforms that might have arisen after teleost genome duplication (11 zebrafish versus 6 human genes) (61) . It is unclear whether each zebrafish membrane-tethered MMP isoform has a specific biological function. Zebrafish MMPs contain typical domains found in the orthologous vertebrate proteins including propeptide, catalytic, and hemopexin domains. The differences in secreted and membranetethered MMPs present in humans and zebrafish might reflect differences in the type and/or spatial distribution of specific ECM substrates.
Gene expression patterns have been described for several zebrafish MMPs and MMP isoforms including mmp2, mmp9, mmp13, mmp14, mmp15, mmp16, mmp17, mmp23, mmp24, and mmp25 (62) (63) (64) (65) (66) (67) (68) (69) (70) (71) . Zebrafish mmp2 exhibits low expression at early embryonic stages prior to somitogenesis and a dynamic pattern at later stages localizing to the somites, pectoral fins, epidermis, otic vesicle, pharyngeal arches, and jaw cartilage (68) . By contrast, embryonic mmp9 expression is restricted © 1996-2015 to the notochord, myeloid cells (similar to mmp13a), and potentially a site of hematopoiesis termed the intermediate cell mass (69) . Unlike human mmp23 that is predominantly expressed in reproductive tissues (72) , zebrafish mmp23bb expression is largely restricted to the liver (65) . Work from our lab has shown that zebrafish mmp14a and mmp14b are broadly expressed during gastrulation and at later stages localize to the pectoral fins, jaw cartilage, neurocranium, and neuromasts of the head (62) . Expression of mmp14a has also been reported in the optic tectum and nerve and in retinal ganglion cells (73) . Recently, mmp25b was shown to exhibit expression in several sensory neurons (63) .
Utilizing semi-quantitative RT-PCR our lab has also shown that other membrane-tethered MMPs display varying expression levels from the onset of gastrulation (shield stage) through 3 days post-fertilization (66). For example, while mmp15a, mmp15b, and mmp16a exhibit stronger expression during gastrulation, mmp16b, mmp17a, and mmp24 do not. All of the membranetethered MMPs are strongly expressed at 24 and 48 hours post-fertilization (62, 66) . Further analyses identified weak and ubiquitous mmp15a expression in the early embryo but tissue-specific expression at later stages in an area resembling the cardinal vein tail plexus and in the brain, mandibular arch, pectoral fins, spinal cord neurons, epidermis, and caudal hematopoietic tissue (66) (Figure 1 ). By contrast, mmp15b is expressed in the early embryo being detected in prechordal plate mesoderm, anterior neural plate, the polster, hindbrain, and pronephric duct (66). At later developmental stages (after 24 hours post-fertilization), mmp15b exhibits highly specific expression in the proctodeum, pharyngeal arches, pharyngeal pouches, caudal notochord, posterior lateral line primordium, and otic vesicle (66) (Figure 2 ). During embryonic development, the composition, density, and rigidity of the ECM each has the potential to regulate multiple cell behaviors including motility, where matrix proteins act as both a physical barrier to directed cell migration and a scaffold that cells move on and through. Studies of tumor cell migration have demonstrated a critical role for membrane-tethered MMPs during both invasion of collagen and transmigration through type IV collagen and laminin containing basement membranes (74, 75) . Notably, membrane-tethered MMPs also cleave fibronectin (76), an ECM protein important for cell behaviors associated with gastrulation in multiple organisms such as mouse (77,78), frog (79, 80) , and zebrafish (81, 82) . The abundant expression of fibronectin and laminin in zebrafish gastrula-stage embryos (81) suggests that membrane-tethered MMPs might play a significant role during this developmental process. Work from our lab has shown that Mmp14a and Mmp14b regulate planar cell polarity underlying convergence and extension gastrulation cell movements (62) . The gastrulation phenotypes produced by morpholinomediated mmp14 knockdown in wild-type embryos are subtle. However, in the compromised genetic background of knypek m119 where a null mutation in the Wnt co-receptor Glypican4 (83) disrupts planar cell polarity, mmp14 knockdown greatly exacerbates the convergence and extension defect (62) (Figure 3 ). These findings suggest that there is a relationship between planar cell polarity and zebrafish Mmp14 function in migrating gastrula cells. Indeed, utilizing a human cancer cell model system, we found that the core planar cell polarity protein Vang-like 2 influences cell surface levels and proteolytic activity of human MMP14 (84) (85) (86) . Our ongoing studies aim to specifically define the role of zebrafish Mmp14 during gastrulation.
Unlike fibronectin, collagens are broadly expressed at later developmental stages (after 24 hours post-fertilization) and also have the potential to influence numerous cell migration events (67, 68, 87) . Zebrafish lack the collagenases Mmp1 and Mmp8 but have two Mmp13 homologs (mmp13a and mmp13b), a collagenase whose human ortholog has overlapping and distinct cleavage substrates compared with MMP1 and MMP8 (60,76). Interestingly, mmp13a exhibits a highly restricted embryonic expression pattern localizing to macrophages (67) where it was shown to regulate their migration after acute injury (88) . In a study by Leigh et al. (64) , mmp17b expression in migrating neural crest cells was investigated utilizing both morpholino-mediated mmp17b knockdown and chemical inhibition of MMP. In each case, neural crest cell migration became altered with cells localizing to the posterior trunk as opposed to being dispersed along the anterior-posterior axis. The authors provide evidence that RECK (REversioninducing-Cysteine-rich protein with Kazal motifs) inhibits human recombinant MMP17 and that zebrafish Mmp17b physically interacts with RECK raising the possibility that these proteins functionally interact to regulate neural crest cell migration (64) .
CHICKEN
Not many MMPs from the chicken have been identified and classified. Those that have include homologs of three of the transmembrane MMPs, MMP14, MMP15, and MMP16 (89, 90) . Although these and other MMP genes have been cloned from chicken, few of these were investigated for expression patterns and roles in development. The chicken genome also includes at least two TIMP genes (91) and a novel simple hemopexin domain containing MMP, MMP22 (50) . One of the most described chicken MMPs during development is MMP2, shown to play a role in neural streak ingression, cornea formation, cell migration during embryogenesis and skeletal and heart development (90, (92) (93) (94) . MMP2 is a gelatinase that in Chicken MMP2 plays a crucial role in the epithelial-mesenchymal transition (EMT) of neural crest cells. During EMT cells transition from static polarized epithelial cells to motile mesenchymal cells (95). This process involves many molecular and morphological changes within the epithelial cells such as loss of polarity and cell-cell adhesion, loss of E-cadherin, and reorganization of the cytoskeleton. Cells must then invade and migrate through the basement membrane, a process that requires proteases that cleave ECM components of the basement membrane. After migrating through the basement membrane, mesenchymal-like cells form new adhesions and interactions with the ECM in their new microenvironment. EMT is an important process for embryonic morphogenesis, wound healing, and cancer metastasis. During chicken development, MMP2 expression increases at the onset of EMT then diminishes after the EMT process is complete. Inhibition studies in chicken embryos show that without MMP2 the cells of the neural crest fail to undergo EMT. Lack of MMP2 does not affect the migration of neural crest cells that have already undergone EMT. These findings were similar although opposite in the somites and dermal tissue. The expression of MMP2 appears as the somites and the dermal tissue begin EMT and also dissipates after EMT. With the inhibition of MMP2 in these tissues, EMT still takes place but cell migration fails after EMT. This indicates that in the neural crest MMP2 is necessary for EMT while in the somites and dermal tissue MMP2 is necessary for cell migration after EMT (92) . MMP2 expression begins in the epiblast cells in the area where the primitive streak forms starting at day 2 of development. MMP11 and MMP16 are also found in the primitive streak and injection of MMP inhibitors produced embryos where primitive streak cells failed to ingress (94) . MMP2, MMP11 and MMP16 have a variety of ECM substrates and it is thought that these MMPs break down the ECM within the primitive streak to allow cells to ingress (94) .
Another tissue in the chicken embryo that expresses MMP2 is the developing cornea (93) . Expression here begins at day 7 and continues throughout the development of the cornea. MMP16 begins to be expressed at day 5 of development and also continues throughout the formation of the cornea. MMP13 is expressed early in cornea development but its expression is gone by day 7. Interestingly, the MMP13 substrate type IX collagen also disappears from the cornea by day 7 (93) . Formation of the cornea starts when the primary stoma swells. Type IX collagen binds hyaluronic acid in the primary stoma. When type IX collagen is cleaved, it releases hyaluronic acid, which retains water, and causes the swelling of the primary stoma. It was shown that MMP2, MMP13, and MMP16 play a role in the cleavage of type IX collagen and consequently the swelling of the Note that the 80 bp band is not visible on these gels. Occasionally, heterozygous knym119 siblings injected with low doses of mmp14 MO failed to develop a detectable C and E phenotype (asterisk). This result is consistent with data obtained from mmp14 MO injected wild-type embryos ( Figure 3D ). Adapted from (62) and used with permission from Elsevier. primary stoma (93) . Once the primary stoma has swollen, neural crest cells migrate into the primary stoma. The neural crest cells express high levels of CD44v6 on their surface. CD44v6 binds to many ECM proteins regulating cell migration and is cleaved by MMP16. Therefore, MMP16 further contributes to the formation of the chicken cornea by regulating cell migration into the cornea (93) .
Chicken MMP2 is also expressed in the forming heart (94) , in the limb buds where the tendons form (92) , in branchial arches (92) , and in the developing long bones (90) ; however, the role of MMP2 in these tissues is unknown. MMP14, MMP13, and MMP16 are also expressed in the forming skeletal tissue indicating they may regulate development of the skeleton (90).
CONCLUSIONS
MMPs are important regulators of cell behavior because they directly influence how cells interact with their microenvironment. Cell-ECM interactions underlie key developmental processes at both the cellular and tissue levels including migration and morphogenesis. The use of non-mammalian developmental model systems has and will continue to provide needed insight for our understanding of MMP function. Work utilizing fly, with its two Mmp genes and many genetic tools, has addressed the question of redundancy and the role of these proteases during fly development (45) . Work utilizing zebrafish, with its amenability to microscopic imaging and genetic manipulation, has identified a role for Mmp14 during gastrulation and an interaction with components of the planar cell polarity pathway (62, 85) . Important areas for future research with these and other non-mammalian model systems include in vivo identification of MMP substrates and dissection of pathways regulating MMP enzymatic activity and vesicular trafficking.
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